146 related articles for article (PubMed ID: 25791449)
1. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors.
Jadav SS; Kaptein S; Timiri A; De Burghgraeve T; Badavath VN; Ganesan R; Sinha BN; Neyts J; Leyssen P; Jayaprakash V
Bioorg Med Chem Lett; 2015 Apr; 25(8):1747-1752. PubMed ID: 25791449
[TBL] [Abstract][Full Text] [Related]
2. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
3. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
6. Epitopes based drug design for dengue virus envelope protein: A computational approach.
Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins.
Mayhoub AS; Khaliq M; Kuhn RJ; Cushman M
J Med Chem; 2011 Mar; 54(6):1704-14. PubMed ID: 21355607
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
[TBL] [Abstract][Full Text] [Related]
11. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
12. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics.
Parikesit AA; Kinanty ; Tambunan US
Pak J Biol Sci; 2013 Dec; 16(24):1836-48. PubMed ID: 24516999
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
14. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2.
de la Guardia C; Stephens DE; Dang HT; Quijada M; Larionov OV; Lleonart R
Molecules; 2018 Mar; 23(3):. PubMed ID: 29547522
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel target sites and an inhibitor of the dengue virus E protein.
Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B
J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
17. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
[TBL] [Abstract][Full Text] [Related]
18. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads.
Gangopadhyay A; Chakraborty HJ; Datta A
J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821
[TBL] [Abstract][Full Text] [Related]
19. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S
Virol J; 2015 Feb; 12():16. PubMed ID: 25886260
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents.
Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J
Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
